To address this, we integrate a large database of over 90 gene expression perturbation signatures, reflecting perturbations of many important breast cancer genes, with the most comprehensive breast cancer gene expression dataset, the METABRIC set, comprising two independent subsets of 774 (the discovery set) and 651 (the validation set) ER+ samples, respectively [3]. The gene discussed is ESR1; the disease is breast cancer.